These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 38017352)

  • 1. Disrupted hypothalamic transcriptomics and proteomics in a mouse model of type 2 diabetes exposed to recurrent hypoglycaemia.
    Castillo-Armengol J; Marzetta F; Rodriguez Sanchez-Archidona A; Fledelius C; Evans M; McNeilly A; McCrimmon RJ; Ibberson M; Thorens B
    Diabetologia; 2024 Feb; 67(2):371-391. PubMed ID: 38017352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High intensity interval training as a novel treatment for impaired awareness of hypoglycaemia in people with type 1 diabetes (HIT4HYPOS): a randomised parallel-group study.
    Farrell CM; McNeilly AD; Hapca S; Fournier PA; Jones TW; Facchinetti A; Cappon G; West DJ; McCrimmon RJ
    Diabetologia; 2024 Feb; 67(2):392-402. PubMed ID: 38010533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sleep deprivation prevents counterregulatory adaptation to recurrent hypoglycaemia.
    Meyhöfer S; Dembinski K; Schultes B; Born J; Wilms B; Lehnert H; Hallschmid M; Meyhöfer SM
    Diabetologia; 2022 Jul; 65(7):1212-1221. PubMed ID: 35445819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic hyperglycaemia increases the vulnerability of the hippocampus to oxidative damage induced during post-hypoglycaemic hyperglycaemia in a mouse model of chemically induced type 1 diabetes.
    McNeilly AD; Gallagher JR; Evans ML; de Galan BE; Pedersen-Bjergaard U; Thorens B; Dinkova-Kostova AT; Huang JT; Ashford MLJ; McCrimmon RJ;
    Diabetologia; 2023 Jul; 66(7):1340-1352. PubMed ID: 37015997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The metabesity factor HMG20A potentiates astrocyte survival and reactive astrogliosis preserving neuronal integrity.
    Lorenzo PI; Martin Vazquez E; López-Noriega L; Fuente-Martín E; Mellado-Gil JM; Franco JM; Cobo-Vuilleumier N; Guerrero Martínez JA; Romero-Zerbo SY; Perez-Cabello JA; Rivero Canalejo S; Campos-Caro A; Lachaud CC; Crespo Barreda A; Aguilar-Diosdado M; García Fuentes E; Martin-Montalvo A; Álvarez Dolado M; Martin F; Rojo-Martinez G; Pozo D; Bérmudez-Silva FJ; Comaills V; Reyes JC; Gauthier BR
    Theranostics; 2021; 11(14):6983-7004. PubMed ID: 34093866
    [No Abstract]   [Full Text] [Related]  

  • 6. Ghrelin does not impact the blunted counterregulatory response to recurrent hypoglycemia in mice.
    Shankar K; Varshney S; Gupta D; Mani BK; Osborne-Lawrence S; Metzger NP; Richard CP; Zigman JM
    Front Endocrinol (Lausanne); 2023; 14():1181856. PubMed ID: 37334290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ventromedial hypothalamic nitric oxide production is necessary for hypoglycemia detection and counterregulation.
    Fioramonti X; Marsollier N; Song Z; Fakira KA; Patel RM; Brown S; Duparc T; Pica-Mendez A; Sanders NM; Knauf C; Valet P; McCrimmon RJ; Beuve A; Magnan C; Routh VH
    Diabetes; 2010 Feb; 59(2):519-28. PubMed ID: 19934009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoglycaemia frequency and physiological response after double or triple doses of once-weekly insulin icodec vs once-daily insulin glargine U100 in type 2 diabetes: a randomised crossover trial.
    Pieber TR; Arfelt KN; Cailleteau R; Hart M; Kar S; Mursic I; Svehlikova E; Urschitz M; Haahr H
    Diabetologia; 2023 Aug; 66(8):1413-1430. PubMed ID: 37308751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypothalamic POMC or MC4R deficiency impairs counterregulatory responses to hypoglycemia in mice.
    Tooke BP; Yu H; Adams JM; Jones GL; Sutton-Kennedy T; Mundada L; Qi NR; Low MJ; Chhabra KH
    Mol Metab; 2019 Feb; 20():194-204. PubMed ID: 30503832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-cell transcriptomic profiling of human pancreatic islets reveals genes responsive to glucose exposure over 24 h.
    Grenko CM; Taylor HJ; Bonnycastle LL; Xue D; Lee BN; Weiss Z; Yan T; Swift AJ; Mansell EC; Lee A; Robertson CC; Narisu N; Erdos MR; Chen S; Collins FS; Taylor DL
    Diabetologia; 2024 Oct; 67(10):2246-2259. PubMed ID: 38967666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal glucagon-like peptide-1: A new player associated with impaired counterregulatory responses to hypoglycaemia in type 1 diabetic mice.
    Jin FX; Wang Y; Li MN; Li RJ; Guo JT
    World J Diabetes; 2024 Aug; 15(8):1764-1777. PubMed ID: 39192849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypothalamic S-nitrosylation contributes to the counter-regulatory response impairment following recurrent hypoglycemia.
    Fioramonti X; Deak A; Deshpande S; Carneiro L; Zhou C; Sayed N; Orban B; Berlin JR; Pénicaud L; Leloup C; Beuve A; Routh VH
    PLoS One; 2013; 8(7):e68709. PubMed ID: 23894333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disrupted Leptin Signaling in the Lateral Hypothalamus and Ventral Premammillary Nucleus Alters Insulin and Glucagon Secretion and Protects Against Diet-Induced Obesity.
    Denroche HC; Glavas MM; Tudurí E; Karunakaran S; Quong WL; Philippe M; Britton HM; Clee SM; Kieffer TJ
    Endocrinology; 2016 Jul; 157(7):2671-85. PubMed ID: 27183315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of somatostatin receptor type 2 antagonism during insulin-induced hypoglycaemia in male rats with prediabetes.
    Hoffman EG; D'Souza NC; Aiken J; Atherley S; Liggins R; Riddell MC
    Diabetes Obes Metab; 2023 Jun; 25(6):1547-1556. PubMed ID: 36734462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. I.c.v. administration of the nonsteroidal glucocorticoid receptor antagonist, CP-472555, prevents exacerbated hypoglycemia during repeated insulin administration.
    Kale AY; Paranjape SA; Briski KP
    Neuroscience; 2006 Jun; 140(2):555-65. PubMed ID: 16626867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carvedilol prevents counterregulatory failure and impaired hypoglycaemia awareness in non-diabetic recurrently hypoglycaemic rats.
    Farhat R; Su G; Sejling AS; Knight N; Fisher SJ; Chan O
    Diabetologia; 2019 Apr; 62(4):676-686. PubMed ID: 30627753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypothalamic nitric oxide in hypoglycemia detection and counterregulation: a two-edged sword.
    Fioramonti X; Song Z; Vazirani RP; Beuve A; Routh VH
    Antioxid Redox Signal; 2011 Feb; 14(3):505-17. PubMed ID: 20518706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent hypoglycemia alters hypothalamic expression of the regulatory proteins FosB and synaptophysin.
    Al-Noori S; Sanders NM; Taborsky GJ; Wilkinson CW; Zavosh A; West C; Sanders CM; Figlewicz DP
    Am J Physiol Regul Integr Comp Physiol; 2008 Nov; 295(5):R1446-54. PubMed ID: 18753263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Counterregulatory hormonal responses to hypoglycaemia in type 1 (insulin-dependent) diabetes: evidence for diminished hypothalamic-pituitary hormonal secretion.
    Frier BM; Fisher BM; Gray CE; Beastall GH
    Diabetologia; 1988 Jul; 31(7):421-9. PubMed ID: 2851469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sexually dimorphic roles for the type 2 diabetes-associated C2cd4b gene in murine glucose homeostasis.
    Mousavy Gharavy SN; Owen BM; Millership SJ; Chabosseau P; Pizza G; Martinez-Sanchez A; Tasoez E; Georgiadou E; Hu M; Fine NHF; Jacobson DA; Dickerson MT; Idevall-Hagren O; Montoya A; Kramer H; Mehta Z; Withers DJ; Ninov N; Gadue PJ; Cardenas-Diaz FL; Cruciani-Guglielmacci C; Magnan C; Ibberson M; Leclerc I; Voz M; Rutter GA
    Diabetologia; 2021 Apr; 64(4):850-864. PubMed ID: 33492421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.